- Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. Cannon, C.P., Weintraub, W.S., Demopoulos, L.A., Vicari, R., Frey, M.J., Lakkis, N., Neumann, F.J., Robertson, D.H., DeLucca, P.T., DiBattiste, P.M., Gibson, C.M., Braunwald, E. N. Engl. J. Med. (2001)